Carl Dambkowski, Chief Medical Officer at Apogee Therapeutics, Inc. (APGE), sold 8,625 shares at $48.62 ($420K) on 2024-12-11, disclosed to the SEC on 2024-12-13.
Scheduled sale ($420k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $48.62 | 4,085 | $199K | 47.3% |
| 2 | $48.62 | 4,085 | $199K | 47.3% |
| 3 | $50.00 | 455 | $23K | 5.4% |
| Total | $48.69 avg | 8,625 | $420K | 100% |
| Filing → |
| ORKA | SELL | 2026-06-12 | $2.5M | — | Filing → |
| APGE | SELL | 2026-06-05 | $433K | — | Filing → |
| ORKA | SELL | 2026-05-22 | $6.2M | — | Filing → |